vs

Side-by-side financial comparison of BILL Holdings, Inc. (BILL) and STEPAN CO (SCL). Click either name above to swap in a different company.

STEPAN CO is the larger business by last-quarter revenue ($604.5M vs $414.7M, roughly 1.5× BILL Holdings, Inc.). STEPAN CO runs the higher net margin — 3.3% vs -0.6%, a 3.9% gap on every dollar of revenue. On growth, BILL Holdings, Inc. posted the faster year-over-year revenue change (14.4% vs 1.9%). Over the past eight quarters, BILL Holdings, Inc.'s revenue compounded faster (13.3% CAGR vs 4.2%).

BILL Holdings, Inc. is an American company based in San Jose, California, that provides automated, cloud-based software for financial operations for small businesses in the United States. A white-labeled, end-to-end payments automation platform, Bill.com Connect is offered to financial institutions as part of their single sign-on online business banking ecosystem.

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

BILL vs SCL — Head-to-Head

Bigger by revenue
SCL
SCL
1.5× larger
SCL
$604.5M
$414.7M
BILL
Growing faster (revenue YoY)
BILL
BILL
+12.5% gap
BILL
14.4%
1.9%
SCL
Higher net margin
SCL
SCL
3.9% more per $
SCL
3.3%
-0.6%
BILL
Faster 2-yr revenue CAGR
BILL
BILL
Annualised
BILL
13.3%
4.2%
SCL

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
BILL
BILL
SCL
SCL
Revenue
$414.7M
$604.5M
Net Profit
$-2.6M
$19.7M
Gross Margin
79.8%
10.7%
Operating Margin
-4.4%
4.7%
Net Margin
-0.6%
3.3%
Revenue YoY
14.4%
1.9%
Net Profit YoY
-107.7%
EPS (diluted)
$-0.03
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BILL
BILL
SCL
SCL
Q1 26
$604.5M
Q4 25
$414.7M
$553.9M
Q3 25
$395.7M
$590.3M
Q2 25
$383.3M
$594.7M
Q1 25
$358.2M
$593.3M
Q4 24
$362.6M
$525.6M
Q3 24
$358.4M
$546.8M
Q2 24
$343.7M
$556.4M
Net Profit
BILL
BILL
SCL
SCL
Q1 26
$19.7M
Q4 25
$-2.6M
$5.0M
Q3 25
$-3.0M
$10.8M
Q2 25
$-7.1M
$11.3M
Q1 25
$-11.6M
$19.7M
Q4 24
$33.5M
$3.4M
Q3 24
$8.9M
$23.6M
Q2 24
$7.6M
$9.5M
Gross Margin
BILL
BILL
SCL
SCL
Q1 26
10.7%
Q4 25
79.8%
9.3%
Q3 25
80.5%
12.0%
Q2 25
80.8%
12.1%
Q1 25
81.2%
12.7%
Q4 24
81.6%
10.8%
Q3 24
82.0%
13.8%
Q2 24
81.0%
12.5%
Operating Margin
BILL
BILL
SCL
SCL
Q1 26
4.7%
Q4 25
-4.4%
1.9%
Q3 25
-5.2%
3.7%
Q2 25
-5.8%
3.0%
Q1 25
-8.1%
4.8%
Q4 24
-6.0%
1.5%
Q3 24
-2.1%
4.4%
Q2 24
-6.5%
3.4%
Net Margin
BILL
BILL
SCL
SCL
Q1 26
3.3%
Q4 25
-0.6%
0.9%
Q3 25
-0.7%
1.8%
Q2 25
-1.8%
1.9%
Q1 25
-3.2%
3.3%
Q4 24
9.3%
0.6%
Q3 24
2.5%
4.3%
Q2 24
2.2%
1.7%
EPS (diluted)
BILL
BILL
SCL
SCL
Q1 26
$0.86
Q4 25
$-0.03
$0.22
Q3 25
$-0.03
$0.47
Q2 25
$0.02
$0.50
Q1 25
$-0.11
$0.86
Q4 24
$-0.06
$0.14
Q3 24
$0.08
$1.03
Q2 24
$0.37
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BILL
BILL
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
$1.8B
$328.4M
Stockholders' EquityBook value
$3.8B
$1.2B
Total Assets
$10.1B
$2.3B
Debt / EquityLower = less leverage
0.48×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BILL
BILL
SCL
SCL
Q1 26
Q4 25
$1.1B
$132.7M
Q3 25
$1.1B
$118.5M
Q2 25
$1.0B
$88.9M
Q1 25
$1.0B
$107.5M
Q4 24
$1.6B
$99.7M
Q3 24
$853.5M
$147.3M
Q2 24
$985.9M
$124.7M
Total Debt
BILL
BILL
SCL
SCL
Q1 26
$328.4M
Q4 25
$1.8B
$626.7M
Q3 25
$1.9B
$655.5M
Q2 25
$1.7B
$658.0M
Q1 25
$1.7B
$659.3M
Q4 24
$1.7B
$625.4M
Q3 24
$914.8M
$688.5M
Q2 24
$914.0M
$657.1M
Stockholders' Equity
BILL
BILL
SCL
SCL
Q1 26
$1.2B
Q4 25
$3.8B
$1.2B
Q3 25
$3.9B
$1.2B
Q2 25
$3.9B
$1.2B
Q1 25
$3.9B
$1.2B
Q4 24
$3.8B
$1.2B
Q3 24
$4.0B
$1.2B
Q2 24
$4.1B
$1.2B
Total Assets
BILL
BILL
SCL
SCL
Q1 26
$2.3B
Q4 25
$10.1B
$2.4B
Q3 25
$10.2B
$2.4B
Q2 25
$10.1B
$2.4B
Q1 25
$9.6B
$2.4B
Q4 24
$9.7B
$2.3B
Q3 24
$9.0B
$2.4B
Q2 24
$9.2B
$2.3B
Debt / Equity
BILL
BILL
SCL
SCL
Q1 26
0.28×
Q4 25
0.48×
0.50×
Q3 25
0.48×
0.53×
Q2 25
0.44×
0.53×
Q1 25
0.43×
0.55×
Q4 24
0.44×
0.53×
Q3 24
0.23×
0.56×
Q2 24
0.22×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BILL
BILL
SCL
SCL
Operating Cash FlowLast quarter
$105.3M
Free Cash FlowOCF − Capex
$103.8M
FCF MarginFCF / Revenue
25.0%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$378.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BILL
BILL
SCL
SCL
Q1 26
Q4 25
$105.3M
$60.0M
Q3 25
$96.9M
$69.8M
Q2 25
$83.8M
$11.2M
Q1 25
$99.5M
$6.9M
Q4 24
$78.7M
$68.3M
Q3 24
$88.6M
$22.7M
Q2 24
$78.6M
$29.5M
Free Cash Flow
BILL
BILL
SCL
SCL
Q1 26
Q4 25
$103.8M
$25.4M
Q3 25
$95.6M
$40.2M
Q2 25
$81.0M
$-14.4M
Q1 25
$98.4M
$-25.8M
Q4 24
$78.3M
$32.1M
Q3 24
$88.6M
$-4.0M
Q2 24
$78.4M
$-208.0K
FCF Margin
BILL
BILL
SCL
SCL
Q1 26
Q4 25
25.0%
4.6%
Q3 25
24.1%
6.8%
Q2 25
21.1%
-2.4%
Q1 25
27.5%
-4.3%
Q4 24
21.6%
6.1%
Q3 24
24.7%
-0.7%
Q2 24
22.8%
-0.0%
Capex Intensity
BILL
BILL
SCL
SCL
Q1 26
Q4 25
0.4%
6.3%
Q3 25
0.3%
5.0%
Q2 25
0.7%
4.3%
Q1 25
0.3%
5.5%
Q4 24
0.1%
6.9%
Q3 24
0.0%
4.9%
Q2 24
0.1%
5.3%
Cash Conversion
BILL
BILL
SCL
SCL
Q1 26
Q4 25
11.99×
Q3 25
6.44×
Q2 25
0.99×
Q1 25
0.35×
Q4 24
2.35×
20.38×
Q3 24
9.94×
0.96×
Q2 24
10.35×
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BILL
BILL

Accounts Payable And Accounts Receivable Solutions$185.9M45%
Spend And Expense Interchange Revenue$166.5M40%
Interest On Funds Held For Customers$39.5M10%
Embedded And Other Solutions$22.8M5%

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

Related Comparisons